SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis

References

• Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44.9.
   Google Scholar
• Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21:33.6.
   PubMedGoogle Scholar
• Buxbaum J. Rheumatology e-edition. Mosby; 2003.
   Google Scholar
• Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999;265:501.23.
   Google Scholar
• Sipe JD, Bartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 1992;148:480.4.
   Google Scholar
• Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 2004;314:363.9.
   Google Scholar
• Liepnieks JJ, Kluve-Beckerman B, Benson MD. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1995;1270:81.6.
   Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24.9.
   Google Scholar
• Sipe JD. Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75.86.
   Google Scholar
• Beach CM, De Beer MC, Sipe JD, Loose LD, De Beer FC. Human serum amyloid A protein. Complete amino acid sequence of a new variant. Biochem J 1992;282 (Pt 2):615.20.
   PubMedGoogle Scholar
• Baba S, Takahashi T, Kasama T, Fujie M, Shirasawa H. A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57. Arch Biochem Biophys 1993;303: 361.6.
   Google Scholar
• Baba S, Masago S, Takahashi T, Kasama T, Sugimura H, Tsugane S, et al. A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995;4:1083.7.
   Google Scholar
• Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, et al. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AAamyloidosis in patients with rheumatoid arthritis. Hum Genet 1999;105:360.6.
   Google Scholar
• Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998;5: 262.5.
   Google Scholar
• Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, et al. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid 2003;10:7.11.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315.24.
   Google Scholar
• Tompson EA, Deeb S, walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers; RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 1988;42:113. 24.
   Google Scholar
• Moriguchi M, Terai C, Koseki Y, Kaneko H, Uesato M, Nishikawa T, et al. Genotypes at SAA1 locus correlate with the clinical severity of AA-amyloidosis. Amyloid 2001;8:115.20.
   PubMedGoogle Scholar
• Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol 2001;13:67.73.
   Google Scholar
• Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 1998;78:535.9.
   PubMedGoogle Scholar
• Yavin EJ, Preciado-Patt L, Rosen O, Yaron M, Suessmuth RD, Levartowsky D, et al. Serum amyloid A-derived peptides, present in human rheumatic synovial fluids, induce the secretion of interferon- gamma by human CD(4)(+) T-lymphocytes. FEBS Lett 2000;472:259.62.
   PubMedGoogle Scholar
• Hatanaka E, Furlaneto CJ, Ribeiro FP, Souza GM, Campa A. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett 2004;91:33.7.
   Google Scholar
• Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, et al. Relative transcriptional activities of SAA1 promoters polymorphic at position .13(T/C): potential association between increased transcription and amyloidosis. Amyloid 2005;12: 26.32.
   Google Scholar
• Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, et al. A novel single-nucleotide polymorphism at the 5��-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001;44:1266.72.
   Google Scholar
• Katz M (editor). Assumption of multiple linear regression, multiple logistic regression, and proportional hazards analysis: In: Multivariable analysis. A practical guide for clinicians. New York: Cambridge University Press; 1999.
   Google Scholar
• Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women�fs Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726.32.
   Google Scholar